Search Results for:

For Patients: Clinical Trials
https://www.inovio.com/for-patients-clinical-trials/
FOR PATIENTS: CLINICAL TRIALS INOVIO is committed to developing new, innovative DNA medicines to treat diseases with urgent global health needs including cancer and infectious diseases. INOVIO currently has the…
INOVIO Reports First Quarter 2021 Financial Results
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Reports-First-Quarter-2021-Financial-Results/default.aspx
INOVIO Reports Second Quarter 2021 Financial Results
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Reports-Second-Quarter-2021-Financial-Results/default.aspx
INOVIO and Advaccine Receive Regulatory Allowance for Two Heterologous Prime-Boost Clinical Trials in China Using INO-4800, INOVIO’s COVID-19 DNA Vaccine Candidate
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-and-Advaccine-Receive-Regulatory-Allowance-for-Two-Heterologous-Prime-Boost-Clinical-Trials-in-China-Using-INO-4800-INOVIOs-COVID-19-DNA-Vaccine-Candidate/default.aspx
INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Doses-First-Participant-in-Phase-2-Trial-for-its-DNA-Vaccine-Against-Middle-East-Respiratory-Syndrome-MERS-a-Coronavirus-Disease/default.aspx
INOVIO to Report Second Quarter 2021 Financial Results on August 9, 2021
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-to-Report-Second-Quarter-2021-Financial-Results-on-August-9-2021/default.aspx
INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-4800
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Expands-Partnership-with-Advaccine-to-Conduct-Global-Phase-3-Efficacy-Trial-of-COVID-19-DNA-Vaccine-Candidate-INO-4800/default.aspx
INOVIO to Present at the Jefferies 2021 Virtual Healthcare Conference
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-to-Present-at-the-Jefferies-2021-Virtual-Healthcare-Conference/default.aspx
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Announces-Appointment-Of-Roger-Dansey-M.D.-to-its-Board-of-Directors/default.aspx
INOVIO’s Pan-COVID-19 Vaccine Candidate (INO-4802) Induces Broad Immunity Against Major Viral Variants in Preclinical Studies
https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIOs-Pan-COVID-19-Vaccine-Candidate-INO-4802-Induces-Broad-Immunity-Against-Major-Viral-Variants-in-Preclinical-Studies/default.aspx